BioElectronics Corporation announced that it has appointed Evomed as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole Heel Pain Relief Therapy in Australia and New Zealand. Evomed will also be promoting the ActiPatch 7-Day Trial Device to assist chronic pain sufferers with an affordable way to trial the device.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00015 USD | 0.00% | 0.00% | 0.00% |
Mar. 25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
Feb. 23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.71M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics Corporation Appoints Evomed as Australian and New Zealand Distributor